Exclusive

Publication

Byline

Location

US Patent Issued to Catalent Ontario on April 21 for "Pharmaceutical formulations of naproxen for soft gel encapsulation and combinations thereof" (Canadian Inventors)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,605,348, issued on April 21, was assigned to Catalent Ontario Ltd. (Windsor, Canada). "Pharmaceutical formulations of naproxen for soft gel en... Read More


US Patent Issued to Orbus Therapeutics on April 21 for "Methods of treating grade 3 astrocytoma" (California Inventors)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,605,349, issued on April 21, was assigned to Orbus Therapeutics Inc. (Menlo Park, Calif.). "Methods of treating grade 3 astrocytoma" was inven... Read More


US Patent Issued to INDUSTRY-ACADEMIC COOPERATION FOUNDATION GYEONGSANG NATIONAL UNIVERSITY on April 21 for "Composition for preventing, ameliorating, or treating disease caused by nitration of tyrosine in proteins comprising tyrosine as effective component" (South Korean Inventors)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,605,350, issued on April 21, was assigned to INDUSTRY-ACADEMIC COOPERATION FOUNDATION GYEONGSANG NATIONAL UNIVERSITY (Gyeongsangnam-do, South K... Read More


US Patent Issued to LUXEMBOURG INSTITUTE OF SCIENCE AND TECHNOLOGY on April 21 for "Method for producing a composition comprising a 3-O-p-coumaroyl ester of tormentic acid from a plant cell culture, applications thereof as antiparasitic agent for the treatment of trypanosomiasis" (Belgian, French Inventors)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,605,351, issued on April 21, was assigned to LUXEMBOURG INSTITUTE OF SCIENCE AND TECHNOLOGY (Esch-sur-alzette, Luxembourg). "Method for produc... Read More


US Patent Issued to THE UNIVERSITY OF NEW BRUNSWICK on April 21 for "Compositions and methods for inhibiting blood cancer cell growth" (Canadian Inventors)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,605,352, issued on April 21, was assigned to THE UNIVERSITY OF NEW BRUNSWICK (Fredericton, Canada). "Compositions and methods for inhibiting b... Read More


US Patent Issued to ACADEMIA SINICA on April 21 for "PDIA4 inhibitors and use thereof for inhibiting Beta-cell pathogenesis and treating diabetes" (Taiwanese Inventors)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,605,353, issued on April 21, was assigned to ACADEMIA SINICA (Taipei City, Taiwan). "PDIA4 inhibitors and use thereof for inhibiting Beta-cell... Read More


US Patent Issued to NEW FRONTIER LABS on April 21 for "Azelaic acid esters in the treatment or prevention of dyslipidemia and associated conditions" (Texas Inventors)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,605,354, issued on April 21, was assigned to NEW FRONTIER LABS LLC (San Antonio). "Azelaic acid esters in the treatment or prevention of dysli... Read More


US Patent Issued to Fidia Farmaceutici on April 21 for "HA-paclitaxel conjugate for treatment of mesothelioma" (Italian Inventors)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,605,355, issued on April 21, was assigned to Fidia Farmaceutici S.p.A. (Abano Terme, Italy). "HA-paclitaxel conjugate for treatment of mesothe... Read More


US Patent Issued to PanTher Therapeutics on April 21 for "Methods of treating pancreatic cancer" (Massachusetts Inventors)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,605,356, issued on April 21, was assigned to PanTher Therapeutics Inc. (Watertown, Mass.). "Methods of treating pancreatic cancer" was invente... Read More


US Patent Issued on April 21 for "Bioactive supplement" (Brazilian Inventor)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,605,357, issued on April 21. "Bioactive supplement" was invented by Wellington Silva (Ipatinga, Brazil). According to the abstract* released ... Read More